Forensic Science SA, Adelaide, Australia.
Forensic Sci Int. 2010 Apr 15;197(1-3):59-66. doi: 10.1016/j.forsciint.2009.12.048. Epub 2010 Jan 13.
In August 2007, four capsules containing white powders, said to have originated from an Israel-based Internet company "Neorganics", were anonymously delivered to the Royal Adelaide Hospital, South Australia. The capsules were analysed and the active components were identified including 4-methylmethcathinone, 2-fluoromethamphetamine, alpha-phthalimidopropiophenone and N-ethylcathinone, all of which were unlisted within South Australian controlled substance regulations. We examined the relevant scientific literature surrounding these chemicals and present both GCMS and NMR data for 4-methylmethcathinone and alpha-phthalimidopropiophenone, which have previously received little attention. We also present the vapour- and condensed-phase infrared spectra (IR) of 4-methylmethcathinone as these have also not been reported in the literature previously. We discuss the issues surrounding whether these chemicals can be classified as controlled substance analogues and the likely impact this could have on prosecutions of individuals distributing these products.
2007 年 8 月，四个装有白色粉末的胶囊被匿名寄到南澳大利亚州皇家阿德莱德医院，据称这些粉末来自以色列的一家互联网公司“Neorganics”。胶囊被分析后，确定了其中的活性成分，包括 4-甲基甲卡西酮、2-氟甲苯丙胺、α-邻苯二甲酰亚氨基丙基苯丙酮和 N-乙基卡西酮，所有这些成分都未列入南澳大利亚州管制物质法规。我们查阅了围绕这些化学物质的相关科学文献，并提供了 4-甲基甲卡西酮和 α-邻苯二甲酰亚氨基丙基苯丙酮的 GCMS 和 NMR 数据，这两种物质以前很少受到关注。我们还提供了 4-甲基甲卡西酮的气相和冷凝相红外光谱（IR），因为这些在文献中以前也没有报道过。我们讨论了这些化学物质是否可以被归类为管制物质类似物，以及这可能对起诉分发这些产品的个人产生的影响。
